Literature DB >> 1313904

Regulation of the Epstein-Barr virus DNA polymerase gene.

F B Furnari1, M D Adams, J S Pagano.   

Abstract

The gene (pol) encoding the Epstein-Barr virus (EBV) DNA polymerase is a member of the "early" class of viral genes which are expressed shortly after activation of latent virus infection. First, mRNA from the EBV-producing cell line, B95-8, treated with 12-O-tetradecanoylphorbol-13-acetate and sodium butyrate to induce lytic replication and expression of this gene was analyzed. Northern (RNA) analysis revealed a message of 3.7 kb found only in induced cells. 5' mapping of pol mRNA by S1 nuclease and primer extension analyses indicates that transcription initiates at tightly clustered sites within a G + C-rich region 126 bp upstream of the open reading frame. The same initiation region was identified in two other EBV-infected cell lines, P3HR1 and Raji, after induction. Second, a 1.29-kb genomic fragment containing this region, when cloned upstream of the chloramphenicol acetyltransferase reporter gene, demonstrated promoter activity in lymphoid cells cotransfected with pEBV-RZ, a genomic expression construct that includes genes for the EBV immediate-early transactivator proteins, BZLF-1 and BRLF-1. Within the upstream 1.29-kb sequence, two regions of 140 bp and 101 bp appear to be needed for promoter activity. These results demonstrate that unlike most EBV genes studied thus far, the pol gene contains multiple transcriptional start sites. The upstream regulatory region of the promoter for the pol gene does not contain canonical promoter elements such as TATA and CAAT boxes and, furthermore, is not constitutively active but requires transactivation by two or more viral proteins.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1313904      PMCID: PMC241041     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

1.  Studies of an Epstein-Barr virus-induced DNA polymerase.

Authors:  R L Miller; R Glaser; F Rapp
Journal:  Virology       Date:  1977-02       Impact factor: 3.616

2.  A STUDY OF MALIGNANT TUMOURS IN NIGERIA BY SHORT-TERM TISSUE CULTURE.

Authors:  J V PULVERTAFT
Journal:  J Clin Pathol       Date:  1965-05       Impact factor: 3.411

3.  Effect of 12-O-tetradecanoyl-phorbol-13-acetate on the replication of Epstein-Barr virus. I. Characterization of viral DNA.

Authors:  J C Lin; J E Shaw; M C Smith; J S Pagano
Journal:  Virology       Date:  1979-11       Impact factor: 3.616

4.  Analysis of the HSV-1 strain 17 DNA polymerase gene reveals the expression of four different classes of pol transcripts.

Authors:  H Bludau; U K Freese
Journal:  Virology       Date:  1991-08       Impact factor: 3.616

5.  Cooperation of EBV DNA polymerase and EA-D(BMRF1) in vitro and colocalization in nuclei of infected cells.

Authors:  A Kiehl; D I Dorsky
Journal:  Virology       Date:  1991-09       Impact factor: 3.616

6.  Induction of virus enzymes by phorbol esters and n-butyrate in Epstein-Barr virus genome-carrying Raji cells.

Authors:  L M Nutter; S P Grill; J S Li; R S Tan; Y C Cheng
Journal:  Cancer Res       Date:  1987-08-15       Impact factor: 12.701

7.  Nucleotide sequence and nuclease hypersensitivity of the Chinese hamster dihydrofolate reductase gene promoter region.

Authors:  J C Azizkhan; J P Vaughn; R J Christy; J L Hamlin
Journal:  Biochemistry       Date:  1986-10-07       Impact factor: 3.162

8.  Sequence and transcription analysis of the human cytomegalovirus DNA polymerase gene.

Authors:  T Kouzarides; A T Bankier; S C Satchwell; K Weston; P Tomlinson; B G Barrell
Journal:  J Virol       Date:  1987-01       Impact factor: 5.103

9.  Both Epstein-Barr virus (EBV)-encoded trans-acting factors, EB1 and EB2, are required to activate transcription from an EBV early promoter.

Authors:  A Chevallier-Greco; E Manet; P Chavrier; C Mosnier; J Daillie; A Sergeant
Journal:  EMBO J       Date:  1986-12-01       Impact factor: 11.598

10.  Mutational analysis of the 5' non-coding region of human immunodeficiency virus type 1: effects of secondary structure on translation.

Authors:  N T Parkin; E A Cohen; A Darveau; C Rosen; W Haseltine; N Sonenberg
Journal:  EMBO J       Date:  1988-09       Impact factor: 11.598

View more
  26 in total

1.  Interferon regulatory factor 2 represses the Epstein-Barr virus BamHI Q latency promoter in type III latency.

Authors:  L Zhang; J S Pagano
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

2.  Epstein-Barr virus LF2 protein regulates viral replication by altering Rta subcellular localization.

Authors:  Andreas M F Heilmann; Michael A Calderwood; Eric Johannsen
Journal:  J Virol       Date:  2010-07-14       Impact factor: 5.103

3.  The Epstein-Barr virus LF2 protein inhibits viral replication.

Authors:  Michael A Calderwood; Amy M Holthaus; Eric Johannsen
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

4.  Activation of the Epstein-Barr virus DNA polymerase promoter by the BRLF1 immediate-early protein is mediated through USF and E2F.

Authors:  C Liu; N D Sista; J S Pagano
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

5.  Essential role of Rta in lytic DNA replication of Epstein-Barr virus.

Authors:  Ayman El-Guindy; Maryam Ghiassi-Nejad; Sean Golden; Henri-Jacques Delecluse; George Miller
Journal:  J Virol       Date:  2012-10-17       Impact factor: 5.103

6.  Different distributions of Epstein-Barr virus early and late gene transcripts within viral replication compartments.

Authors:  Atsuko Sugimoto; Yoshitaka Sato; Teru Kanda; Takayuki Murata; Yohei Narita; Daisuke Kawashima; Hiroshi Kimura; Tatsuya Tsurumi
Journal:  J Virol       Date:  2013-04-03       Impact factor: 5.103

7.  Two phenylalanines in the C-terminus of Epstein-Barr virus Rta protein reciprocally modulate its DNA binding and transactivation function.

Authors:  Lee-Wen Chen; Vineetha Raghavan; Pey-Jium Chang; Duane Shedd; Lee Heston; Henri-Jacques Delecluse; George Miller
Journal:  Virology       Date:  2009-02-15       Impact factor: 3.616

8.  Cerebrospinal fluid CD4+ T cells from a multiple sclerosis patient cross-recognize Epstein-Barr virus and myelin basic protein.

Authors:  Trygve Holmøy; Espen Østhagen Kvale; Frode Vartdal
Journal:  J Neurovirol       Date:  2004-10       Impact factor: 2.643

9.  S-Like-Phase Cyclin-Dependent Kinases Stabilize the Epstein-Barr Virus BDLF4 Protein To Temporally Control Late Gene Transcription.

Authors:  Yoshitaka Sato; Takahiro Watanabe; Chihiro Suzuki; Yuichi Abe; H M Abdullah Al Masud; Tomoki Inagaki; Masahiro Yoshida; Takeshi Suzuki; Fumi Goshima; Jun Adachi; Takeshi Tomonaga; Takayuki Murata; Hiroshi Kimura
Journal:  J Virol       Date:  2019-04-03       Impact factor: 5.103

10.  RAZ, an Epstein-Barr virus transdominant repressor that modulates the viral reactivation mechanism.

Authors:  F B Furnari; V Zacny; E B Quinlivan; S Kenney; J S Pagano
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.